Table 2.
Molecular interactions of lead ligands with the amino acid residues in the binding region of SARS-CoV 2’s Main protease
S/N | Compounds | Binding affinity (kcal/mol) | No. of residues involved in H-Bond | Residues involved in hydrogen bond (Distance, Å) | Residues involved in hydrophobic interaction |
---|---|---|---|---|---|
1 | 3-O-(6-galloylglucoside) | − 8.6 | 7 | Leu141 (3.00, 2.99), Ser144 (3.01, 3.00), His163 (3.04), Thr26 (3.08, 2.87), Thr24 (3.23), Gly143 (3.10, 2.88) and His41 (3.28) | Met49, Thr25, Asn142, Cys145, Met165 and Gln189 |
2 | C33 | − 8.3 | 4 | Ser144 (2.92), Gly143 (2.94), Cys145 (3.15) and Asn142 (2.82) | Asn142, Cys145, Met49, Met165 and Glu166 |
3 | Remdesivir | − 8.2 | 4 | Gly143 (3.08), Leu141 (2.70), Ser144 (2.85) and His163 (3.28, 3.07) | Glu166, Met165, Arg188, Asp187, His41, Met49, Cys145, Leu27, Thr26 and Thr25 |